Genomics and proteomics are two subfields of molecular biology that study the structure and function of living organisms at a molecular level. Genomics is the study of an organism’s full set of genes in order to understand the genetic processes that control their growth and behavior. Proteomics is the study of an organism’s proteins, which are the molecular machines that control the functioning of cells in the body. Both disciplines are important to gaining insight into the workings of the human body, from the genetic basis of disease to better understanding how food and drugs are metabolized. Genomics is the science of characterizing and studying an organism’s entire genetic context, which consists of its DNA, RNA, and proteins. By determining the condensed sequence of an organisms’ genome, scientists are able to create detailed information on the genetic basis of its phenotype and learn more about the molecular functioning of its gene products. By understanding gene-disease associations, scientists can identify mutated genes associated with various diseases and develop treatments based on this knowledge. Genomics also helps us understand an organism’s evolutionary history and the degree of gene flow from one generation to the next. Proteomics is the science of systematically analyzing all of the proteins in a single organism in order to gain a better understanding of the cellular processes and biological pathways that are active in the organism. Proteins are the large molecular machines that make up the majority of the functioning cell, and by studying their interactions with other molecules, scientists can gain insight into how different diseases develop and spread throughout an organism’s body. Proteomics also informs our understanding of how drugs can be used to target a specific protein, and can aid in drug development by helping to identify mechanisms of action for potential therapeutic candidates. In conclusion, Genomics and Proteomics are powerful tools for biologists to study and understand the functioning of living organisms at the molecular level.
Title : A case of vile vindictive primary CNS vasculitis
George Diaz, Memorial Healthcare Systems, United States
Title : Novel important cellular responses, signaling mechanisms and therapeutic options in vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : The role of beliefs, perception, and behavioural patterns in the evolution of psychophysical disorders
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : How have we eliminated infection: From the bone to brain?
Thomas J Webster, Interstellar Therapeutics, United States
Title : Cervical stenosis-induced chronic cerebrospinal fluid flow restriction as a contributing cause of dementia
Joe Sam Robinson, Mercer University, United States